BiotechTube

tadalafil + sildenafil

ApprovedCompleted
0 watching 0 views this week🔥 Hot
85
Hype Score

Development Stage

✓
Pre-clinical
✓
Phase 1
✓
Phase 2
✓
Phase 3
5
Approved
Indication / Disease

Impotence

Conditions

Impotence

Trial Timeline

Oct 1, 2003 → Nov 1, 2004

NCT ID
NCT00547092

About tadalafil + sildenafil

tadalafil + sildenafil is a approved stage product being developed by Eli Lilly for Impotence. The current trial status is completed. This product is registered under clinical trial identifier NCT00547092. Target conditions include Impotence.

Hype Score Breakdown

Clinical
30
Activity
20
Company
10
Novelty
10
Community
12

Clinical Trials (4)

NCT IDPhaseStatus
NCT01352507ApprovedCompleted
NCT00547352ApprovedCompleted
NCT00547092ApprovedCompleted
NCT00547287Phase 3Completed

Competing Products

20 competing products in Impotence

See all competitors
ProductCompanyStageHype Score
tadalafilEli LillyApproved
85
tadalafil + sildenafilEli LillyApproved
85
tadalafil + placebo + tadalafil + tadalafil + tadalafil + placeboEli LillyPhase 3
77
GPI 1485EisaiPhase 2
52
tadalafilEli LillyApproved
85
tadalafil + sildenafilEli LillyPhase 3
77
tadalafilEli LillyPhase 3
77
tadalafil + placebo + tadalafil + tadalafilEli LillyPhase 3
77
tadalafil + PlaceboEli LillyPhase 3
77
tadalafil + tadalafil + placeboEli LillyPhase 3
77
tadalafil + tadalafil + placeboEli LillyPhase 3
77
Fluvastatin-sodiumNovartisPhase 3
77
Sildenafil CitratePfizerApproved
84
UK0369,003 + Cialis (Tadalafil)PfizerPhase 2
51
Viagra (Sildenafil citrate)PfizerApproved
84
sildenafil citratePfizerApproved
84
Placebo + Viagra (sildenafil citrate)PfizerApproved
84
UK-369,003PfizerPhase 2
51
Viagra (Sildenafil Citrate) 100 mgPfizerApproved
84
Viagra (Sildenafil citrate)PfizerApproved
84

Other Products from Eli Lilly

Insulin Glargine + Insulin Lispro Premix (mid-mixture and low-mixture)Approved
85
Olanzapine + PlaceboApproved
85
exenatide and sitagliptin + exenatide and placeboApproved
85
Tirzepatide + PlaceboApproved
85
tadalafilApproved
85